hydromorphone hydrochloride - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
JURNISTA hydromorphone hydrochloride 16 mg prolonged release tablet blister pack AUST R: 141533Active ingredients:
hydromorphone hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800 226 334
|
Deletion from market:
30 Apr 2023
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An unregistered product has been approved for supply under Section 19A. The approval holder Medsurge Pty Ltd can be contacted on 1300 788 261 or sales@medsurge.com.au for details on supply.
|
JURNISTA hydromorphone hydrochloride 32 mg prolonged release tablet blister pack AUST R: 141534Active ingredients:
hydromorphone hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800 226 334
|
Deletion from market:
30 Apr 2023
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An unregistered product has been approved for supply under Section 19A. The approval holder Medsurge Pty Ltd can be contacted on 1300 788 261 or sales@medsurge.com.au for details on supply.
|
JURNISTA hydromorphone hydrochloride 4 mg prolonged release tablet blister pack AUST R: 155995Active ingredients:
hydromorphone hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800 226 334
|
Deletion from market:
30 Apr 2023
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
|
JURNISTA hydromorphone hydrochloride 64 mg prolonged release tablet blister pack AUST R: 141535Active ingredients:
hydromorphone hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800 226 334
|
Deletion from market:
30 Apr 2023
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
|
JURNISTA hydromorphone hydrochloride 8 mg prolonged release tablet blister pack AUST R: 141508Active ingredients:
hydromorphone hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800 226 334
|
Deletion from market:
30 Apr 2023
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An unregistered product has been approved for supply under Section 19A. The approval holder Medsurge Pty Ltd can be contacted on 1300 788 261 or sales@medsurge.com.au for details on supply.
|